Evidence map›Paper›PMID 31758285›Full record

ReviewCurrent diabetes reports2019

Early-Life Arsenic Exposure, Nutritional Status, and Adult Diabetes Risk.

Ana Navas-Acien, Miranda J Spratlen, Ahlam Abuawad, Nancy J LoIacono, Anne K Bozack, Mary V Gamble

Open access · greenAbstract readReview
In one paragraph

Review in Current diabetes reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana Navas-AcienDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 W168th Street, New York, NY, 10032, USA. an2737@cumc.columbia.edu.
Miranda J SpratlenDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 W168th Street, New York, NY, 10032, USA.
Ahlam AbuawadDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 W168th Street, New York, NY, 10032, USA.
Nancy J LoIaconoDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 W168th Street, New York, NY, 10032, USA.
Anne K BozackDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 W168th Street, New York, NY, 10032, USA.
Mary V GambleDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 W168th Street, New York, NY, 10032, USA.
Columbia University · US

Funding

Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Supplemental Training in Making Data FAIR and AI/ML ReadyT32ES007322 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Pam R Factor-Litvak, Allison Kupsco · 2000 to 2026
$12.1M
IMSD at Columbia's Mailman School of Public HealthR25GM062454 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOLDSMITH, JEFF, MARTINS, SILVIA SABOIA · 2002 to 2019
$7.3M
Low-level Arsenic Exposure and Cardiovascular Disease in Multi-Ethnic Adults (MESA As)R01ES028758 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2018 to 2022
$3.6M
Arsenic, Epigenetics and Incident Cardiovascular Disease in American IndiansR01ES025216 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI FALLIN, M DANIELE, NAVAS-ACIEN, ANA · 2015 to 2018
$2.2M
Effects of Arsenic Exposure on 5-methylcytosine and 5-hydroxymethylcytosine, and Effect Modification by Nutritional StatusF31ES029019 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BOZACK, ANNE KRISTINA · 2018 to 2019
$48k
Arsenic, metabolism and metabolic syndrome in the Strong Heart StudyF31ES027796 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI SPRATLEN, MIRANDA JONES · 2017 to 2017
$34k
NIEHS NIH HHS F31 ES027796NIEHS NIH HHS F31 ES029019NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P42 ES010349NIEHS NIH HHS R01 ES025216NIEHS NIH HHS R01 ES028758NIEHS NIH HHS T32 ES007322NIGMS NIH HHS R25 GM062454
6 · The paper itself

Abstract

purpose of reviewIn utero influences, including nutrition and environmental chemicals, may induce long-term metabolic changes and increase diabetes risk in adulthood. This review evaluates the experimental and epidemiological evidence on the association of early-life arsenic exposure on diabetes and diabetes-related outcomes, as well as the influence of maternal nutritional status on arsenic-related metabolic effects. RECENT

findingsFive studies in rodents have evaluated the role of in utero arsenic exposure with diabetes in the offspring. In four of the studies, elevated post-natal fasting glucose was observed when comparing in utero arsenic exposure with no exposure. Rodent offspring exposed to arsenic in utero also showed elevated insulin resistance in the 4 studies evaluating it as well as microRNA changes related to glycemic control in 2 studies. Birth cohorts of arsenic-exposed pregnant mothers in New Hampshire, Mexico, and Taiwan have shown that increased prenatal arsenic exposure is related to altered cord blood gene expression, microRNA, and DNA methylation profiles in diabetes-related pathways. Thus far, no epidemiologic studies have evaluated early-life arsenic exposure with diabetes risk. Supplementation trials have shown B vitamins can reduce blood arsenic levels in highly exposed, undernourished populations. Animal evidence supports that adequate B vitamin status can rescue early-life arsenic-induced diabetes risk, although human data is lacking. Experimental animal studies and human evidence on the association of in utero arsenic exposure with alterations in gene expression pathways related to diabetes in newborns, support the potential role of early-life arsenic exposure in diabetes development, possibly through increased insulin resistance. Given pervasive arsenic exposure and the challenges to eliminate arsenic from the environment, research is needed to evaluate prevention interventions, including the possibility of low-cost, low-risk nutritional interventions that can modify arsenic-related disease risk.

Indexed as

Nutritional StatusAdultAnimalsArsenicBlood GlucoseDiabetes MellitusFemaleFetal BloodGene ExpressionHumansInfant, NewbornInsulin ResistanceMicePregnancyPrenatal Exposure Delayed EffectsRatsArsenicBlood GlucoseVitamin B ComplexArsenicDiabetesEarly-life exposuresNutritionOne-carbon metabolism

Identifiers

PMID31758285
PMCPMC7004311
OpenAlexW2990766040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.